JULIE MONROE: Open Payments
NPI 1629800131 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $264 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $98 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $51 |
| Celgene Corporation | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Shionogi Inc | 1 | $21 |
| ViiV Healthcare Company | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $15 |
Products named: MAVYRET, VOWST, OPDIVO, PIFELTRO, ZENPEP, Fetroja, DOVATO, NUZYRA.
Industry payments across IN — which companies pay providers there.
